ArticleCurrent treatment options in rheumatology2021

Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?

Minghua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.